TCMR

AcronymDefinition
TCMRThe Church Music Report
TCMRTranslational Comparative Medical Research
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
Abbreviations ABMR: Antibody-mediated rejection Abs: Antibodies AGH: Anti-human globulin CDC: Complement dependent cytotoxicity CDC-AHG: Complement dependent cytotoxicity-antihuman-globulin enhanced DSA: Donor-specific antibodies DTT: Dithiothreitol ELISA: Enzyme-Linked Immune Sorbent Assay FCXM: Flow-cytometry cross-match HLA: Human leukocyte antigens i-DSA: Immunodominant DSA IVIg: Intravenous polyvalent immunoglobulin KTx: Kidney transplantation MFI: Mean fluorescence intensity MM: Mismatch POD: Postoperative day PCR-SSO: Polymerase chain reaction sequence specific oligonucleotides PCR-SSP: Polymerase Chain reaction single strand polymorphisms PRA: Panel reactive antibodies TCMR: T-cell mediated rejection XM: Cross-match.
Approximately 90% of AR is TCMR, which involves [CD4.sup.+] and [CD8.sup.+] T cells by activating perforin/granzyme degranulation pathways [24].
Among rejection recipients without PCAR, TCMR is often sensitive to steroid therapy [14].
A T cell immune response to the donated organ can lead to T cell mediated rejection (TCMR), which is a complication detrimental to the survival of the transplanted organ, stated the company.
The diagnosis of acute TCMR was based on the following criteria: IA, cases with significant interstitial infiltration (>25% of parenchyma affected, i2 or i3), and foci of moderate tubulitis (t2); IB, cases with significant interstitial infiltration (>25% of parenchyma affected, i2 or i3), and foci of severe tubulitis (t3); IIA, cases with mild-to-moderate intimal arteritis (v1); IIB, cases with severe intimal arteritis comprising >25% of the luminal area (v2); III, cases with "transmural" arteritis and/or arterial fibrinoid change and necrosis of medial smooth muscle cells with accompanying lymphocytic inflammation (v3) [7].
In transplant, a T cell immune response to the donated organ can lead to T cell mediated rejection (TCMR), which is a complication detrimental to the survival of the transplanted organ.
It is conceivable that, in moderate to severe cases of T-cell-mediated rejection (TCMR), helper T cells can activate humoral immunity and stimulate the production of alloreactive antibodies.
In the long-term, patients experiencing clinical dysfunction with AMR have the worst 5-year graft survival compared with TCMR or no rejection [58].
However, the mechanism of ABMR is far from being fully elucidated, and the long-term survival of these allografts is greatly reduced when compared to that of grafts without rejection or history of T cell-mediated rejection (TCMR) [2, 6].
We found a predominant intraglomerular expression of T-bet in ABMR patients that was distinct from that in TCMR patients.